((Automated translation by Reuters, please see disclaimer https://bit.ly/rtrsauto))
(Corrects paragraph 7 to reflect that the outlook was revised three times, not four)
Glenview Capital Management, a health care company, will meet with senior executives of CVS Health CVS.N , a troubled health care company, on Monday to suggest ways to improve operations, The Wall Street reported Sunday Newspaper ().
Hedge fund founder Larry Robbins has amassed a large position in CVS, which represents about $700 million of his $2.5 billion hedge fund, according to the report, citing a person familiar with the matter.
CVS said it “maintains regular dialogue with the investment community as part of our robust shareholder and analyst engagement program,” and said it cannot comment on engagement with specific companies or individuals.
Glenview did not immediately respond to a Reuters request for comment.
Speculation has grown among fund managers that an activist investor might step in to push CVS to make changes that would boost its stock price.
Investment firm Sachem Head Capital Management built a new 0.2% stake in the company during the second quarter, according to a regulatory filing in August.
In early August, CVS cut its full-year earnings forecast to $6.40 to $6.65 per share, from previously forecasting at least $7.00. This is at least the fourth time that CVS has lowered its outlook for the current year.
It also announced a multi-year plan to save $2 billion in costs through measures such as streamlining operations and using artificial intelligence and automation across its business.
